Indaptus Therapeutics, Inc. (INDP) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.65
Day's range
$1.88

Indaptus Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
HRT FINANCIAL LP 08/14/2026 206.08 K $618.00 K   100.00% 0.18%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 56.47 K $169.41 K   109.09% 0.05%
JANE STREET GROUP, LLC 08/14/2026 53.81 K $161.43 K   100.00% 0.05%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 33.65 K $100.96 K   100.00% 0.03%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 13.97 K $41.90 K   100.00% 0.01%
MILLENNIUM MANAGEMENT LLC 08/14/2026 11.59 K $34.76 K   100.00% 0.01%
MORGAN STANLEY 08/13/2026 8.94 K $26.81 K   231.33% 0.01%
UBS GROUP AG 08/13/2026 478 $1.43 K   100.00% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 17 $51   0.00% 0.00%
CITADEL ADVISORS LLC 09/02/2026 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 0 $0   -100.00% 0.00%

Indaptus Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 13 institutional investors and hedge funds held shares of Indaptus Therapeutics Inc. The most heavily invested institutionals were:

HRT FINANCIAL LP: 206,077

GEODE CAPITAL MANAGEMENT, LLC: 56,470

JANE STREET GROUP, LLC: 53,811

VANGUARD CAPITAL MANAGEMENT LLC: 33,652

VANGUARD FIDUCIARY TRUST CO: 13,967

MILLENNIUM MANAGEMENT LLC: 11,586

0.33% of Indaptus Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 385.06 K shares in the last 24 months. This purchase volume represents approximately $720.06 K in transactions.